Benjamin Machinas Beneski is CTO & VP at Allogene Therapeutics, Inc. (ALLO). They have made 6 open-market trades across 1 company since 2025, most recently 2026-03-31.
CIK 0002057918
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ALLO | 195,338 | $256K |
Shares reported on the most recent Form 4, priced at the 2026-04-02 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALLO | SELL | 2026-03-31 | 2026-04-02 | $2.50 | $7K | -12.5% | -9.3% | -15.1% |
| ALLO | SELL | 2026-03-16 | 2026-03-18 | $2.47 | $12K | +5.7% | +13.8% | -9.0% |
| ALLO | SELL | 2026-03-02 | 2026-03-04 | $2.60 | $19K | -1.6% | +4.8% | -17.3% |
| ALLO | SELL | 2026-02-02 | 2026-02-04 | $1.73 | $13K | +20.0% | +27.8% | +20.8% |
| ALLO | SELL | 2025-11-17 | 2025-11-19 | $1.22 | $959 | +4.7% | +10.9% | +68.8% |
| ALLO | SELL | 2025-03-14 | 2025-03-18 | $1.98 | $11K | -8.3% | -14.2% | -18.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.